Institutional investors purchased a net $1.0 million shares of GLPG during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 21.21% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Sold 200.00 shares of Galapagos NV